SUMMARY FOUR-YEAR REVIEW CONTINUED

Four-year
Performance indicators average 2017 2016 2015 2014

Gross profit margin % 23.7 24.4 23.4 23.2 24.0

EBITDA margin % 6.9 7.5 7.0 6.2 6.9
Operating margin % 5.9 6.5 6.0 5.2 5.9
EPS cps 189.4 75.0 212.0 239.2 231.5
HEPS cps 187.9 74.7 206.0 239.1 231.6
Inventory days Days 83 84 81 78 90
Debtors days Days 19 20 17 17 20
Creditors days Days 53 61 48 46 56
Net working capital days Days 49 43 50 49 54
Return on equity % – 66.9 52.8 40.2 –

Four-year
compound
Share performance growth % 2017 2016 2015 2014

Actual shares at year-end* (‘000) 68 859 274 794 446 181 818 180 000

WANOS (‘000) 67 816 617 241 831 181 320 176 474
Share price at year-end cps 23.98 n/a n/a n/a
Net asset value per share (WANOS) cps (38) 138.43 347.22 717.81 569.54
Net asset value per share (actual
shares at year-end) cps (38) 131.56 105.69 715.85 558.38
* After share split in September 2016

A comprehensive four-year review is available on the website.

38 DIS-CHEM PHARMACIES Annual Integrated Report for the financial year ended 28 February 2017